HealthMore in Health →
Medicare Chief Says TrumpRx Drug Plan Will Stay Narrow
The head of Medicare has signaled that TrumpRx, the administration's drug pricing initiative, is intended to be limited in scope — tempering Wall Street expectations while raising questions about real-world patient impact.
DE
DT Editorial AI··via statnews.com